Sarver Vrooman Wealth Advisors purchased a new stake in shares of iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 21,314 shares of the company’s stock, valued at approximately $513,000. iShares iBonds Dec 2032 Term Corporate ETF comprises approximately 0.3% of Sarver Vrooman Wealth Advisors’ investment portfolio, making the stock its 10th largest holding.
A number of other institutional investors and hedge funds have also modified their holdings of the company. Trust Co. of Vermont acquired a new position in iShares iBonds Dec 2032 Term Corporate ETF in the 2nd quarter valued at $152,000. Praetorian Wealth Management Inc. lifted its position in iShares iBonds Dec 2032 Term Corporate ETF by 24.3% during the 2nd quarter. Praetorian Wealth Management Inc. now owns 197,602 shares of the company’s stock worth $4,978,000 after acquiring an additional 38,612 shares during the last quarter. Ballast Advisors LLC bought a new stake in iShares iBonds Dec 2032 Term Corporate ETF during the first quarter valued at about $30,000. Farmers National Bank grew its position in shares of iShares iBonds Dec 2032 Term Corporate ETF by 5.0% in the first quarter. Farmers National Bank now owns 33,584 shares of the company’s stock valued at $849,000 after purchasing an additional 1,603 shares during the last quarter. Finally, Parallel Advisors LLC increased its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 1.0% in the first quarter. Parallel Advisors LLC now owns 244,230 shares of the company’s stock worth $6,172,000 after purchasing an additional 2,429 shares during the period.
iShares iBonds Dec 2032 Term Corporate ETF Price Performance
Shares of NYSEARCA IBDX traded down $0.05 during trading hours on Thursday, hitting $24.02. 211,501 shares of the company’s stock were exchanged, compared to its average volume of 274,661. iShares iBonds Dec 2032 Term Corporate ETF has a 1-year low of $23.90 and a 1-year high of $26.00. The company’s 50-day moving average price is $24.65 and its 200-day moving average price is $24.98.
About iShares iBonds Dec 2032 Term Corporate ETF
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
- First Watch’s Growth Story Meets a Reality Check
- Down 50% and Climbing Again: 3 AI Stocks Rebuilding After Brutal Pullbacks
- Micron’s Earnings Reveal Why the AI Memory Boom May Last Longer
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
